55289-0559 Ondansetron

Product NDC:

55289-0559

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

TABLET, ORALLY DISINTEGRATING

Administration Route:

Oral

Substances:

Name: Ondansetron

Strength: 4.0

Unit: mg/1

Packages:

Code: 55289-0559-03

Description: 3 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (55289-559-03)

Effective Date: Jan. 6, 2010

Discontinued: Aug. 2, 2018

Code: 55289-0559-05

Description: 5 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (55289-559-05)

Effective Date: Jan. 6, 2010

Discontinued: Aug. 2, 2018

Code: 55289-0559-06

Description: 6 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (55289-559-06)

Effective Date: April 21, 2017

Discontinued: Aug. 2, 2018

Code: 55289-0559-10

Description: 10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (55289-559-10)

Effective Date: Jan. 6, 2010

Discontinued: Aug. 2, 2018

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

No Longer Used

CanMED and the Oncology Toolbox